CFTR and cystic fibrosis: In particular, to assess the effects on bronchial epithelia and immune system of CF patients, we used immortalized CuFi-1 cells expressing F508del CFTR, and the macrophage-like differentiated THP-1 cells treated with the pharmacological inhibitor of CFTR, CFTRinh-172 (Poerio et al., 2022).